Learn how to build a comprehensive cryptographic inventory and strengthen quantum‑safe readiness using Microsoft Security ...

It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the first data with the ...

Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...

Microsoft is taking over a data center construction project in Texas after OpenAI declined to pursue it, in a move that will ...

VerifiedX has introduced a privacy layer for Bitcoin using zero-knowledge proofs, as demand grows for confidential on-chain ...

The UK designated Xinbi Guarantee as an enabler of crypto scammers and human trafficking weeks ago. Telegram is still hosting ...

Abstract: Base station (BS) sleeping is an effective way to reduce the energy consumption of mobile networks. Previous efforts to design sleeping control algorithms mainly rely on stochastic traffic ...

Beam is now in the strongest position of all companies advancing a genetic therapy for alpha-1 antitrypsin deficiency, according to analysts at William Blair. Beam Therapeutics’ investigational base ...

Beam Therapeutics said Wednesday its study of a gene editing treatment for alpha-1 antitrypsin deficiency helped restore protein production in patients with the rare liver and lung disease, the most ...

Abstract: Unmanned aerial vehicle (UAV)-enabled Internet of Things (IoT) systems are considered an effective solution for maritime environmental monitoring. However, in the maritime data collection ...